Allena pharma Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

Listing Results Allena pharma Contact Number

Allena Pharmaceuticals Crunchbase Company Profile & …

2 hours ago Crunchbase.com Show details

215-791-0105

Contact Email [email protected] Phone Number 215-791-0105. Allena Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to …

Founded: 2011
Founder: Robert Gallotto

Category: Contact NumberShow more

Allena Pharmaceuticals Join Us

7 hours ago Allenapharma.com Show details

Allena Pharmaceuticals, Inc. is an equal employment opportunity employer and does not discriminate against any applicant because of race, creed, color, age, national origin, ancestry, religion, gender, sexual orientation, disability, genetic information, veteran status, military status, application for military service, or any other class

Category: Contact NumberShow more

Allena Pharmaceuticals Provides Update on Clinical

2 hours ago Ir.allenapharma.com Show details

617-430-7577

Investor Relations Contact: Ashley R. Robinson LifeSci Advisors, LLC Tel: 617-430-7577 [email protected] Media Contact Adam Daley Berry & Company Public Relations 212-253-8881 [email protected] Source: Allena Pharmaceuticals, Inc.

Category: Contact NumberShow more

Allena Pharmaceuticals TERMS OF USE

2 hours ago Allenapharma.com Show details

Kevin Brennan is the Vice President Finance at Allena Pharmaceuticals. Kevin joined the Allena team in 2011 as the Associate Director, Finance and has played an integral role in financial strategy, planning and operations, and the development and monitoring of systems designed to manage the organization’s finance and reporting.

Category: Contact NumberShow more

News Release Details allenapharma.com

3 hours ago Ir.allenapharma.com Show details

212-362-1200

Investor Contact Hannah Deresiewicz Stern Investor Relations, Inc. 212-362-1200 [email protected] Media Contact Adam Daley Berry & Company Public Relations 212-253-8881 [email protected] Source: Allena Pharmaceuticals, Inc.

Category: Contact NumberShow more

ALNA Allena Pharmaceuticals Inc. BioPharmCatalyst

5 hours ago Biopharmcatalyst.com Show details

NEWTON, Mass., Aug. 10, 2021 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) ("Allena" or the "Company"), a late-stage biopharmaceutical company deploying its novel oral biologic platform to discover, develop and commercialize first-in-class, oral enzyme therapeutics for difficult-to-treat metabolic diseases, today reported

Category: Contact NumberShow more

Allena Pharmaceuticals Ireland Limited VisionNet

4 hours ago Vision-net.ie Show details

Allena Pharmaceuticals Ireland Limited was set up on Tuesday the 21st of March 2017. Their current partial address is Dublin, and the company status is Normal. The company's current directors have been the director of 0 other Irish companies between them. Allena Pharmaceuticals Ireland Limited has 1 shareholder.

Category: Contact NumberShow more

Allena Pharmaceuticals Number of Employees Macrotrends

9 hours ago Macrotrends.net Show details

Allena Pharmaceuticals number of employees from 2016 to 2021. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis

Category: Contact NumberShow more

Hyperoxaluria Is Reduced and allenapharma.com

8 hours ago Allenapharma.com Show details

Kevin Brennan is the Vice President Finance at Allena Pharmaceuticals. Kevin joined the Allena team in 2011 as the Associate Director, Finance and has played an integral role in financial strategy, planning and operations, and the development and monitoring of systems designed to manage the organization’s finance and reporting.

Category: Contact NumberShow more

ServiceTitan Crunchbase

2 hours ago Crunchbase.com Show details

855-899-0970

Contact Email [email protected] Phone Number 855-899-0970. ServiceTitan is a service management software that helps home services businesses generate more leads, book more appointments, and close more sales. Founded in 2012 by Ara Mahdessian and Vahe Kuzoyan, whose fathers were a contractor and plumber, respectively, the company was born

Category: Contact NumberShow more

Allena Pharmaceuticals Crunchbase

9 hours ago Crunchbase.com Show details

Allena Pharmaceuticals has 4 current employee profiles, including Non Executive Director Mark Fitzpatrick. Mark Fitzpatrick Non Executive Director. Louis Brenner President & Chief Executive Officer, Allena Pharmaceuticals. Louis Brenner Chief Operating Officer. Hugh Wight Senior Vice President Technical Operations.

Category: Contact NumberShow more

Investor FAQs allenapharma.com

2 hours ago Ir.allenapharma.com Show details

617-467-4577

Allena’s headquarters are located at One Newton Executive Park, Suite 202, Newton, MA 02462. The main office number is 617-467-4577.

Category: Contact NumberShow more

News Release Details Allena Pharmaceuticals, Inc.

9 hours ago Ir.allenapharma.com Show details

About Allena Pharmaceuticals. Allena Pharmaceuticals, Inc. is a specialty biopharmaceutical company focused on developing and commercializing non-systemic protein therapeutics to treat metabolic and orphan diseases. Allena’s lead program, ALLN-177, is currently conducting a Phase 2b clinical trial in patients with hyperoxaluria.

Category: Contact NumberShow more

Establishing Safety and Efficacy of allenapharma.com

3 hours ago Allenapharma.com Show details

617-467-4577

contact us at: 617-467-4577 x398 or [email protected] • ClinicalTrials.gov Identifier: NCT03847090 • Eudra-CT Number: 2018-000921-29 • Sponsor: Allena Pharmaceuticals www.allenapharma.com • Contract Research Organization: Medpace, 5375 Medpace Way Cincinnati, OH 45227

Category: Contact NumberShow more

ALLENA PHARMACEUTICALS, INC. MarketScreener.com

5 hours ago Marketscreener.com Show details

Allena Pharmaceuticals, Inc. is a late-stage, clinical biopharmaceutical company. The Company is engaged in developing and commercializing oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney disorders.

Category: Contact NumberShow more

Clinical Trials Duke Department of Surgery Duke University

5 hours ago Surgery.duke.edu Show details

919-668-6290

Reference Number: 00086666 Clinical Trials: N/A. 9.) Evaluate the Safety and Efficacy of ALLN-177 in Patients with Enteric Hyperoxaluria: A Phase III Randomized, Placebo-Controlled Study Phase: 3 Principal Investigator: Michael Lipkin Sponsor: Allena Pharmaceuticals Contact: Whitney Franz Phone: 919-668-6290 Reference Number: 00091760

Category: Contact NumberShow more

Hedge Funds Nibbling On Allena Pharmaceuticals Yahoo

9 hours ago Finance.yahoo.com Show details

Contact Us . Contact Us Is Allena Pharmaceuticals, Inc. (NASDAQ:ALNA) The number of long hedge fund bets inched up by 2 lately.

Category: Contact NumberShow more

How Do Analysts Feel About Allena Pharmaceuticals Inc

5 hours ago Baxterreport.com Show details

The total number of common shares currently owned by the public is 57.93 million. ALNA does have institutional investors; and they hold 30.10% of the stock. Allena Pharmaceuticals Inc. – Insider Activity and Holdings. Moreover, the latest SEC filings also revealed that stock came across 0 new insider purchases involving 0 shares.

Category: Contact NumberShow more

PRIVACY POLICY allenapharma.com

3 hours ago Allenapharma.com Show details

Kevin Brennan is the Vice President Finance at Allena Pharmaceuticals. Kevin joined the Allena team in 2011 as the Associate Director, Finance and has played an integral role in financial strategy, planning and operations, and the development and monitoring of systems designed to manage the organization’s finance and reporting.

Category: Contact NumberShow more

Hyperuricemia (Metabolic Disorder) Drugs In Development

9 hours ago Marketresearch.com Show details

Allena Pharmaceuticals Inc Arthrosi Therapeutics Inc AstraZeneca Plc FortuneRock (China) Ltd Contact Us Disclaimer List of Tables Number of Products under Development for Hyperuricemia, 2021 Number of Products under Development by Companies, 2021 Number of Products under Development by Companies, 2021 (Contd..1)

Category: Contact NumberShow more

News Release Details allenapharma.com

7 hours ago Ir.allenapharma.com Show details

28-Day Treatment Advances Program toward Anticipated Pivotal Studies in 2017. NEWTON, Mass., February 10, 2016 – Allena Pharmaceuticals, Inc., a specialty biopharmaceutical company focused on developing and commercializing innovative, non-systemic, oral protein therapeutics to treat metabolic and orphan diseases, today announced …

Category: Contact NumberShow more

Arena Pharmaceuticals Email Format arenapharm.com Emails

4 hours ago Rocketreach.co Show details

Arena Pharmaceuticals Email Format. Arena Pharmaceuticals uses 4 email formats, with first_initial last (ex. [email protected]) being used 97.9% of the time. Get Verified Emails for Arena Pharmaceuticals Employees. Arena Pharmaceuticals's Email Format. Percentage.

Category: Contact NumberShow more

Allena Pharmaceuticals, Inc. (ALNA) Stock Major Yahoo

5 hours ago Finance.yahoo.com Show details

Find out the direct holders, institutional holders and mutual fund holders for Allena Pharmaceuticals, Inc. (ALNA).

Category: Contact NumberShow more

ALLENA PHARMACEUTICALS, INC. : ALNA Stock Price

7 hours ago Marketscreener.com Show details

Allena Pharmaceuticals, Inc. is a late-stage, clinical biopharmaceutical company. The Company is engaged in developing and commercializing oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney disorders. The Company is focused on metabolic disorders that result in excess accumulation of certain metabolites that

Category: Contact NumberShow more

Allena Pharmaceuticals Reports Second Quarter 2021

1 hours ago Finance.yahoo.com Show details

NEWTON, Mass., Aug. 10, 2021 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) (“Allena” or the “Company”), a late-stage biopharmaceutical company deploying its novel oral

1. Author: Allena Pharmaceuticals, Inc.

Category: Contact NumberShow more

What Do Analysts Have To Say About Allena Baxter Report

3 hours ago Baxterreport.com Show details

The total number of common shares currently owned by the public is 55.02 million. ALNA does have institutional investors; and they hold 34.80% of the stock. Allena Pharmaceuticals Inc. – Insider Activity and Holdings. Moreover, the latest SEC filings also revealed that stock came across 1 new insider purchases involving 83,721 shares.

Category: Contact NumberShow more

Allena Pharmaceuticals Announces $28 Million Registered

9 hours ago Finance.yahoo.com Show details

NEWTON, Mass., July 13, 2021 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage, biopharmaceutical company dedicated to developing and commercializing first-in-class

Category: Contact NumberShow more

Allena Lawrence Senior Social Media Strategist

3 hours ago Linkedin.com Show details

View Allena Lawrence’s profile on LinkedIn, the world’s largest professional community. Allena has 9 jobs listed on their profile. See the complete profile on LinkedIn and discover Allena’s

Title: Senior Social Media Strategist …
Location: Greater Chicago
1. 500+ connections

Category: Contact NumberShow more

Allena Pharmaceuticals Increases Previously Yahoo

9 hours ago Finance.yahoo.com Show details

Allena Pharmaceuticals, Inc. is a late-stage biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare and severe

Category: Contact NumberShow more

An Inpatient Study of ALLN346 (Engineered Urate Oxidase

7 hours ago Clinicaltrials.gov Show details

Allena Pharmaceuticals: ClinicalTrials.gov Identifier: NCT04987242 Other Study ID Numbers: ALLN-346-201 : First Posted: August 3, 2021 Key Record Dates: Last Update Posted: August 9, 2021 Last Verified: August 2021 Individual Participant Data (IPD) Sharing Statement: Plan to Share IPD: No

Category: Contact NumberShow more

Stock Market Daily: Allena Pharmaceuticals (NASDAQ:ALNA

1 hours ago Stockmarketdaily.co Show details

Allena Pharmaceuticals last announced its quarterly earnings data on August 9th, 2021. The reported ($0.24) EPS for the quarter, missing the consensus estimate of ($0.21) by $0.03. Allena Pharmaceuticals has generated ($1.01) earnings per share over the last year (($0.91) diluted earnings per share).

Category: Contact NumberShow more

Why Allena Pharmaceuticals Inc. (NASDAQ: ALNA) Should Be

1 hours ago Marketingsentinel.com Show details

Allena Pharmaceuticals Inc. (NASDAQ:ALNA)’s traded shares stood at 0.67 million during the last session, with the company’s beta value hitting 2.15. At the close of trading, the stock’s price was $0.83, to imply a decrease of -1.23% or -$0.01 in intraday trading. The ALNA share’s 52-week hig

Category: Contact NumberShow more

Ellen Prosek Marietta College Columbus LinkedIn

9 hours ago Linkedin.com Show details

Contact me via e-mail at EllenProsek@yahoo.com. People & Culture Business Partner at Allena Pharmaceuticals Greater Boston. Kate Booth

Title: Operations Manager / District …
Location: Columbus, Ohio, United States
Connections: 2

Category: Contact NumberShow more

Allena Pharmaceuticals Inc (ALNA) Price StockNews

6 hours ago Stocknews.com Show details

ALNA has a higher number of analysts covering the stock than 33.99% of Pharmaceutical Products stocks. In the Pharmaceutical Products industry, MBRX , XCUR and BLPH are the three stocks most similar to Allena Pharmaceuticals Inc regarding the price target and analyst recommendation information presented here.

Category: Contact NumberShow more

James Topper General Partner @ Frazier Crunchbase

6 hours ago Crunchbase.com Show details

James Topper joined Frazier Healthcare in 2003 as a Venture Partner and became a General Partner in 2005.James Topper is a member of the firm's Biopharma Venture team. Since joining Frazier Healthcare, James Topper has led multiple Biopharma Venture investments including Incline Therapeutics that was acquired by The Medicines Company for up.

Category: Contact NumberShow more

Leslie Bransfield's email & phone number Principal

2 hours ago Signalhire.com Show details

View Leslie Bransfield's phone: +1-xxx-xxx-4542's profile as Principal Consultant at MetroWest Pharma Solutions, located in Greater Boston. Find contacts: direct phone number, email address, work experience.

Category: Phone NumberShow more

Gino Santini Board Member @ Intarcia Crunchbase

6 hours ago Crunchbase.com Show details

Gino Santini has served on our board of directors since March 2012. Gino Santini currently serves on the board of directors of AMAG Pharmaceuticals, Inc. and Allena Pharmaceuticals, Inc. and is retired from a distinguished career with Eli Lilly …

Category: Contact NumberShow more

Allena Pharmaceuticals Inc. (ALNA): An Intriguing

5 hours ago Stocksregister.com Show details

Allena Pharmaceuticals Inc. (NASDAQ:ALNA) at last check was buoying at $0.85 on Friday, August 20, with a fall of -3.42% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $0.88 and 5Y monthly beta was reading 2.16 with its price kept flo

Category: Contact NumberShow more

Is Allena Stock a good investment? ALNA Macroaxis

9 hours ago Macroaxis.com Show details

Allena Pharmaceuticals is trading at 0.82 as of the 6th of October 2021, a -7.87 percent decrease since the beginning of the trading day. The stock's open price was 0.89. Get the latest Allena Pharmaceuticals detailed stock quotes, stock trade data, stock price info, and performance analysis, including Allena Stock investment advice, charts, stats and more.

Category: Contact NumberShow more

Allena Pharmaceuticals, Inc. (ALNA) Stock Guide Askfinny

1 hours ago Askfinny.com Show details

Analyst Predictions. 3. What is ALNA stock forecast (i.e., prediction)? Based on ALNA analyst price targets, ALNA stock forecast is $6.13 (for a year from now). That means the average analyst price target for ALNA stock is $6.13. The prediction is based on 4 analyst estimates.

Category: Contact NumberShow more

About Turos Capital AG

5 hours ago Turoscapital.com Show details

Since 1984 active in the pharmaceutical, biotech and medical sectors as a board member, business lawyer, founder, active investor and family and investor representative In addition to the companies listed above, Thomas was involved in: EngMab AG, VECAP Venture Capital Partners AG, Antares Pharma Inc., Permatec Group, Jago Group

Category: Contact NumberShow more

SRO List Food and Drug Administration

2 hours ago Accessdata.fda.gov Show details

3. SRO List. -. You can search the list by entering the DUNS NUMBER, BUSINESS NAME, or TICKER SYMBOL in the search criteria. The SRO list is a comprehensive and important resource to check regularly, however, it is not definitive. There are some situations where a financial interest may constitute a prohibited financial interest in an SRO, even

Category: Contact NumberShow more

About Us Alcresta Therapeutics

Just Now Alcresta.com Show details

Dr. Margolin also served as President and CEO of Allena Pharmacauticals which he also co-founded and where he currently serves as Chairman of the Board. Prior to Allena and Alcresta, Dr. Margolin co-founded Alnara Pharmaceuticals in 2008, where he was President and CEO until 2010 when the company was acquired by Eli Lilly.

Category: Contact NumberShow more

Allena Pharmaceuticals : Wedbush Adjusts Allena

7 hours ago Marketscreener.com Show details

Allena Pharmaceuticals : Wedbush Adjusts Allena Pharmaceuticals' Price Target to $4 From $5 on Stock Dilution, Keeps Outperform Rating 08/16/2021 …

Category: Contact NumberShow more

Patrick Norman Sr. Engineer II Tech Transfer and Tech

1 hours ago Linkedin.com Show details

Patrick Norman Sr. Engineer II Tech Transfer and Tech Services Albany, New York, United States 471 connections

Title: Sr. Engineer II Tech Transfer …
Location: Albany, New York, United States
Connections: 471

Category: Tech SupportShow more

ALNA Stock Price Pattern Around Earnings Allena

2 hours ago Marketchameleon.com Show details

Detect patterns in Allena Pharmaceuticals (ALNA) stock behavior before and after earnings releases. You can use this table to quickly see how Allena Pharmaceuticals (ALNA) stock price tends to perform around earnings. Options and stock traders can use the historical data to evaluate potential risk/rewards before trading an earnings announcement.

Category: Contact NumberShow more

Laurence MercierLafond Sr Clinical Site LinkedIn

1 hours ago Linkedin.com Show details

View Laurence Mercier-Lafond’s profile on LinkedIn, the world’s largest professional community. Laurence has 6 jobs listed on their profile. See the complete profile on LinkedIn and discover

Title: Clinical Research at Acceleron …
Location: Boston, Massachusetts, United States
1. 500+ connections

Category: Contact NumberShow more

HIRSCHMAN ORIN SC 13G Filing Concerning ALNA …

8 hours ago Whalewisdom.com Show details

Allena Pharmaceuticals, Inc. (Name of Issuer) Common Stock, $.001 Par Value Per Share (Title of Class of Securities) 018119107 (CUSIP Number) January 20, 2021 (Date of Event Which Requires Filing of this Statement)

Category: Contact NumberShow more

All Time Past 24 Hours Past Week Past month

Please leave your comments here:

Popular Brands

Amazon
Abbvie
Aia
Asml
Att
Amgen
Apple
Adobe
Aptar
Acc
Adidas
Aak
Aes